ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: Updated guidance for the era of vaccines and viral variants

Ian M. Gralnek; Cesare Hassan; Alanna Ebigbo; Andre Fuchs; Ulrike Beilenhoff; Giulio Antonelli; Raf Bisschops; Marianna Arvanitakis; Pradeep Bhandari; Michael Bretthauer; Michal F. Kaminski; Vicente Lorenzo-Zuniga; Enrique Rodriguez de Santiago; Peter D. Siersema; Tony C. Tham; Konstantinos Triantafyllou; Alberto Tringali; Andrei Voiosu; George Webster; Marjon de Pater; Björn Fehrke; Mario Gazic; Tatjana Gjergek; Siiri Maasen; Wendy Waagenes; Mario Dinis-Ribeiro; Helmut Messmann

doi:10.1055/a-1700-4897

Endoscopy, Table of Contents

Endoscopy 2022; 54(02): 211-216
DOI: 10.1055/a-1700-4897

Position Statement

ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: Updated guidance for the era of vaccines and viral variants

Ian M. Gralnek‡^*

¹Ellen and Pinchas Mamber Institute of Gastroenterology and Hepatology, Emek Medical Center, Afula, Israel and Rappaport Faculty of Medicine Technion Israel Institute of Technology, Haifa, Israel

,

Cesare Hassan^*

²Endoscopy Unit, IRCCS Humanitas Clinical and Research Center, Rozzano, Milan, Italy

³Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy

,

Alanna Ebigbo

⁴III Medizinische Klinik Universitätsklinikum Augsburg, Augsburg, Germany

,

Andre Fuchs

⁴III Medizinische Klinik Universitätsklinikum Augsburg, Augsburg, Germany

,

Ulrike Beilenhoff

⁵European Society of Gastroenterology Nurses and Associates (ESGENA)

,

Giulio Antonelli

⁶Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Rome, Italy

⁷Gastroenterology and Digestive Endoscopy Unit, Ospedale dei Castelli di Ariccia, Rome, Italy

,

Raf Bisschops

⁸Department of Gastroenterology and Hepatology, Catholic University of Leuven (KUL), TARGID, University Hospitals Leuven, Leuven, Belgium

,

Marianna Arvanitakis

⁹Erasme University Hospital, Brussels, Belgium

,

Pradeep Bhandari

¹⁰Gastroenterology, Portsmouth Hospital NHS Trust, Portsmouth, United Kingdom

,

Michael Bretthauer

¹¹Clinical Effectiveness Research Group, University of Oslo, and Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway

,

Michal F. Kaminski

¹²Department of Cancer Prevention and Department of Oncological Gastroenterology, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

,

Vicente Lorenzo-Zuniga

¹³Department of Gastroenterology, University and Polytechnic La Fe Hospital/IIS La Fe, Valencia. Spain

,

Enrique Rodriguez de Santiago

¹⁴Department of Gastroenterology and Hepatology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain

,

Peter D. Siersema

¹⁵Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands

,

Tony C. Tham

¹⁶Division of Gastroenterology, Ulster Hospital, Dundonald, Belfast, Northern Ireland

,

Konstantinos Triantafyllou

¹⁷Hepatogastroenterology Unit, Second Department of Internal Medicine - Propaedeutic, Medical School, National and Kapodistrian University of Athens, Attikon University General Hospital, Athens, Greece

,

Alberto Tringali

¹⁸Digestive Endoscopy Unit, Fondazione IRCCS-Istituto Nazionale Tumori, Milan, Italy

,

Andrei Voiosu

¹⁹Department of Gastroenterology and Hepatology, Colentina Clinical Hospital, Bucharest, Romania

²⁰Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

,

George Webster

²¹Department of Gastroenterology, University College London Hospitals, London, United Kingdom

,

Marjon de Pater

²²Amsterdam UMC location AMC, Amsterdam, The Netherlands

,

Björn Fehrke

²³Department of Pneumonology, Inselspital, University Hospital, Bern, Switzerland

,

Mario Gazic

²⁴General Hospital Bjelovar, Bjelovar, Croatia

,

Tatjana Gjergek

²⁵University Medical Centre, Ljubljana, Slovenia

,

Siiri Maasen

²⁶Tallinn Healthcare College, Tallinn, Estonia

,

Wendy Waagenes

²⁷Hvidovre Hospital, Copenhagen, Denmark

,

Mario Dinis-Ribeiro

²⁸Porto Comprehensive Cancer Center (Porto.CCC) and RISE@CI-IPOP (Health Research Network), Porto, Portugal

,

Helmut Messmann

⁴III Medizinische Klinik Universitätsklinikum Augsburg, Augsburg, Germany

› Author Affiliations

Abstract

Full Text

References

References
1 Baden LR, El Sahly HM, Essink B. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021; 384: 403-416
2 Polack FP, Thomas SJ, Kitchin N. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383: 2603-2615
3 Voysey M, Costa Clemens SA, Madhi SA. et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet 2021; 397: 881-891
4 Thomas SJ, Moreira ED, Kitchin N. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med 2021;
5 Sadoff J, Gray G, Vandebosch A. et al. Safety and efficacy of single-dose Ad26. COV2.S vaccine against Covid-19. N Engl J Med 2021; 384: 2187-2201
6 Lopez Bernal J, Andrews N, Gower C. et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med 2021; 385: 585-594
7 European Centre for Disease Prevention and Control (ECDC). COVID-19 Vaccine Tracker [cited 2021 Oct 4]. Available from: https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab
8 Bar-On YM, Goldberg Y, Mandel M. et al. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N Engl J Med 2021; 385: 1393-1400
9 Krause PR, Fleming TR, Peto R. et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet 2021; 398: 1377-1380
10 The WHO is right to call a temporary halt to COVID vaccine boosters. Nature 2021; 596: 317
11 World Health Organization. Rational use of personal protective equipment for COVID-19 and considerations during severe shortages. https://www.who.int/publications/i/item/rational-use-of-personal-protective-equipment-for-coronavirus-disease-(covid-19)-and-considerations-during-severe-shortages
12 Ebigbo A, Karstenson JG, Bhat P. et al. Impact of the COVID-19 pandemic on gastrointestinal endoscopy in Africa. Endosc Int Open 2020; 8: E1097-E1101
13 Antonelli G, Karsensten JG, Bhat P. et al. Resuming endoscopy during COVID-19 pandemic: ESGE, WEO and WGO Joint Cascade Guideline for Resource Limited Settings. Endosc Int Open 2021; 9: E543-E551
14 Gralnek IM, Hassan C, Beilenhoff U. et al. ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy 2020; 52: 483-490
15 Gralnek IM, Hassan C, Beilenhoff U. et al. ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: An update on guidance during the post-lockdown phase and selected results from a membership survey. Endoscopy 2020; 52: 891-898
16 Suzuki T, Hayakawa K, Ainai A. et al. Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers. J Infect Chemother 2021; 27: 120-122
17 Ingram C, Downey V, Roe M. et al. COVID-19 prevention and control measures in workplace settings: a rapid review and meta-analysis. Int J Environ Res Public Health 2021; 18: 7847
18 World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected [cited 2020 Apr 3]. Available from: https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125
19 Centers for Disease Control (CDC). Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic [cited 2020 Apr 4]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html
20 Bartoszko JJ, Farooqi MAM, Alhazzani W. et al. Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: A systematic review and meta-analysis of randomized trials. Influenza Other Respir Viruses 2020; 14: 365-373
21 Naaber P, Tserel L, Kangro K. et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. Lancet Reg Health Eur 2021;
22 Goel RR, Painter MM, Apostolidis SA. et al. mRNA vaccination induces durable immune memory to SARS-CoV-2 with continued evolution to variants of concern. bioRxiv 457229 [Preprint] 2021;
23 Shrotri M, Navaratnam AMD, Nguyen V. et al. Spike-antibody waning after second dose of BNT162b2 or ChAdOx1. Lancet 2021; 398: 385-387
24 Chemaitelly H, Tang P, Hasan MR. et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med 2021;
25 Centers for Disease Control and Prevention (CDC). Why CDC measures vaccine effectiveness [cited 2020 Sep 4]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness/why-measure-effectiveness/breakthrough-cases.html
26 Gallais F, Gantner P, Bruel T. et al. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine 2021; 71: 103561
27 Gazit S, Shlezinger R, Perez G. et al. Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections. medRxiv 21262415 [Preprint]
28 Antonelli M, Penfold RS, Merino J. et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis 2021;
29 Bergwerk M, Gonen T, Lustig Y. et al. Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med 2021; 385: 1474-1484
30 Sultan S, Siddique SM, Singh S. et al. AGA Rapid Review and Guideline for SARS-CoV2 testing and endoscopy post-vaccination: 2021 Update. Gastroenterology 2021; 161: 1011-1029.e11
31 European Centre for Disease Prevention and Control (ECDC). Infection prevention and control for COVID-19 in healthcare settings – first update. https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-infection-prevention-and-control-healthcare-settings-march-2020.pdf
32 Hanson KE, Caliendo AM, Arias CA. et al. Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: Serologic testing. Clin Infect Dis 2020;
33 Dinnes J, Deeks JJ, Adriano A. et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev 2020; 8: CD013705
34 McDade TW, Demonbreun AR, Sancilio A. et al. Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history. Sci Rep 2021; 11: 17325
35 Wang Z, Muecksch F, Schaefer-Babajew D. et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature 2021; 595: 426-431